Beta-Blockers Are the Only Safe Pillar During Pregnancy
Of the four pillars of chronic heart failure therapy, only beta-blockers (specifically β1-selective agents like metoprolol, carvedilol, or bisoprolol) can be safely continued during pregnancy. The other three pillars—ACE inhibitors/ARBs/ARNIs, mineralocorticoid receptor antagonists (MRAs), and SGLT2 inhibitors—are all contraindicated 1, 2.
Contraindicated Medications (Must Stop)
ACE Inhibitors/ARBs/ARNIs
- Absolutely contraindicated throughout pregnancy due to fetotoxicity 1
- First trimester exposure increases congenital anomaly risk (OR 3.2,95% CI 1.0-9.6) 3
- Second and third trimester exposure causes renal dysgenesis, oligohydramnios, growth restriction, and fetal death
- Stop immediately upon pregnancy confirmation—no need to discontinue long before conception, but switch as soon as pregnancy is known 3
Mineralocorticoid Receptor Antagonists (MRAs)
- Spironolactone should be avoided due to antiandrogenic effects in the first trimester 1
- Eplerenone lacks safety data in pregnancy 1
- Discontinue when pregnancy is confirmed or planned 2, 4
SGLT2 Inhibitors
- Contraindicated in pregnancy 2
- Insufficient safety data for use during gestation
- Must be stopped before or immediately upon pregnancy recognition
Safe Medication: Beta-Blockers
Beta-blockers are indicated for all pregnant patients with heart failure if tolerated 1:
- Preferred agents: β1-selective drugs (metoprolol, carvedilol, bisoprolol) 2, 4
- Avoid atenolol specifically—associated with fetal growth restriction 1
- Continue throughout pregnancy at therapeutic doses 4
- Important caveat: Newborns require 24-48 hour monitoring after delivery for hypoglycemia, bradycardia, and respiratory depression 1
Alternative Strategies for Pregnancy
Since three of the four pillars are contraindicated, substitute with pregnancy-compatible alternatives:
For Afterload Reduction (replacing ACE-I/ARB/ARNI)
- Hydralazine plus nitrates (isosorbide dinitrate) 1, 4
- These provide afterload reduction without fetal toxicity
For Volume Management
- Diuretics (furosemide, hydrochlorothiazide) only if pulmonary congestion is present 1
- Use cautiously—may decrease placental blood flow
- Avoid routine use for peripheral edema alone
Anticoagulation Considerations
- Prophylactic anticoagulation recommended for hospitalized pregnant patients with acute heart failure 4
- For chronic heart failure with EF <35%, continue thromboprophylaxis throughout pregnancy and six weeks postpartum 4
- Use LMWH or vitamin K antagonists depending on gestational stage 1
Critical Clinical Pitfall
The most dangerous error is continuing ACE-I/ARB/ARNI into the second and third trimesters, which causes severe fetal renal damage. Even first-trimester exposure carries significant risk 3. Preconception counseling is essential to transition medications before pregnancy occurs, but if pregnancy is unplanned, immediate medication adjustment is mandatory 2, 4.
Postpartum Management
Once delivered and hemodynamically stable, immediately restart full guideline-directed medical therapy including ACE-I/ARB/ARNI and MRAs 1, 4. For breastfeeding mothers who require ACE inhibitors, benazepril, captopril, or enalapril are preferred agents with established safety data 1.